MoglingBio closes seed investment round with Kizoo Technology Capital. MoglingBio, a privately held biotech company, has announced today that it …
Continue reading “Kizoo invests in rejuvenation startup Mogling Bio”
Funding used to accelerate vascular treatment development ahead of next year’s clinical trials in humans. Elastrin Therapeutics, a privately held …
Continue reading “Kizoo portfolio company Elastrin Therapeutics closes $10 million funding round”
Kizoo provides seed funding for Elastrin Therapeutics to develop ground-breaking new technology capable of reversing tissue and organ calcification. It …
Continue reading “Elastrin limbers up for success with Kizoo funding boost”
The latest longevity updates from our investment news desk. Stock markets rallied in the past week, with investors boosted …
Continue reading “Longevity investment bulletin: Mesoblast, Endogena, NeuroSense and more.”
Harvard spin-off closes $5.5m of additional funding to accelerate the development of Therapeutic Mitochondria Transplantation as a new treatment modality. …
Mogling Bio is rejuvenating older stem cells to target age-related disease and restore the function of the aging immune system. …
Continue reading “Is aging a question of order vs disorder?”
Be involved and invested in the greatest investment opportunity of all time – longevity. November heralds mists, mellow fruitfulness… and …
Continue reading “The lifespan revolution is upon us – get involved and get ahead”
Forever Healthy Foundation confirms the 2022 programme and full speaker list for Berlin event. The Forever Healthy Foundation has announced …
Continue reading “Rejuvenation Startup Summit 2022 announces programme and speakers”
The biotech platform that is leveraging one of the cornerstones of evolution – mitochondria. Mitochondria play a crucial role in …
Continue reading “Cellvie – unlocking the power of cell-derived medicines”
